Arvinas (NASDAQ:ARVN – Get Rating) and Avenue Therapeutics (NASDAQ:ATXI – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, valuation, analyst recommendations, risk and institutional ownership. Profitability This table compares Arvinas and Avenue Therapeutics’ net margins, […]
FDA committees voted 8 yes, 14 no on whether the data provided to support the benefits of IV tramadol outweigh the risks for the management of acute pain.
FDA committees voted 8 yes, 14 no on whether the data provided to support the benefits of IV tramadol outweigh the risks for the management of acute pain.